# Q-Learning FCS Clustering System for AML Classification

A reinforcement learning approach to automated AML status classification using flow cytometry data. This project demonstrates the application of Q-learning to medical diagnostics through clinically-informed feature discretization and two-phase progressive training.

## üéØ Project Overview

This system uses Q-learning (a reinforcement learning algorithm) to learn optimal clustering strategies for AML classification based on flow cytometry standard (FCS) data. The approach is unique in that it:

1. **Uses feature-based discretization**: Feature bins are configurable per marker rather than arbitrary quantiles
2. **Employs two-phase progressive training**: 
   - Phase 1: Quality optimization on AML+ samples only
   - Phase 2: Diagnostic refinement on labeled mixed samples
3. **Supports GPU acceleration**: Can use RAPIDS cuML for faster clustering on compatible GPUs
4. **Provides comprehensive visualizations**: Ideal for science fair presentations and educational purposes

## üî¨ Scientific Motivation

Flow cytometry is a powerful tool for AML (Acute Myeloid Leukemia) diagnosis and classification. In AML, abnormal blast cells accumulate in bone marrow and blood. Key markers for AML analysis include:

- **CD45-ECD**: A pan-leukocyte marker (common leukocyte antigen) that helps distinguish different cell populations. In AML, blast cells typically show dim to moderate CD45 expression compared to mature lymphocytes.
- **SS Log (Side Scatter)**: Measures cell granularity and internal complexity. AML blasts often have characteristic side scatter properties that differ from normal cells.
- **FS Lin (Forward Scatter)**: Indicates cell size, useful for identifying cell populations.
- **Additional markers** (IgG1-FITC, IgG1-PE, IgG1-PC5, IgG1-PC7): Isotype controls used to establish baseline fluorescence.

The combination of CD45 and side scatter is particularly powerful for identifying abnormal blast populations characteristic of AML. This system learns optimal clustering strategies from these marker patterns rather than relying on fixed clinical thresholds, using reinforcement learning to adapt to data variations.

## üìã Requirements

### Python Dependencies

```bash
pip install -r requirements.txt
```

### Core Dependencies:
- `numpy>=1.21.0` - Numerical computing
- `pandas>=1.3.0` - Data manipulation
- `scikit-learn>=1.0.0` - Machine learning algorithms
- `fcsparser>=0.2.0` - FCS file parsing
- `matplotlib>=3.4.0`, `seaborn>=0.11.0` - Visualization
- `PyYAML>=5.4.0` - Configuration management
- `tqdm>=4.62.0` - Progress bars

### Optional (GPU Acceleration):
- `cuml>=23.0.0` - RAPIDS cuML for GPU clustering
- `cudf>=23.0.0` - RAPIDS cuDF for GPU DataFrames

**Note**: cuML requires NVIDIA GPU with CUDA support. The system automatically falls back to CPU if GPU is unavailable.

## üöÄ Installation

### Standard Installation (CPU)

```bash
# Clone the repository
git clone https://github.com/mabanana/q-table-fcs-clustering.git
cd q-table-fcs-clustering

# Install dependencies
pip install -r requirements.txt
```

### GPU Installation (Optional)

For GPU acceleration with RAPIDS cuML:

```bash
# Install RAPIDS (requires CUDA-enabled GPU)
# See https://rapids.ai/start.html for installation instructions
conda create -n rapids-23.12 -c rapidsai -c conda-forge -c nvidia \
    cuml=23.12 python=3.10 cudatoolkit=11.8

conda activate rapids-23.12
pip install -r requirements.txt
```

## üìä Data Preparation

Place your FCS files in the appropriate directories:

```
data/
‚îú‚îÄ‚îÄ positive/           # AML+ samples for Phase 1 training
‚îÇ   ‚îú‚îÄ‚îÄ patient001.fcs
‚îÇ   ‚îú‚îÄ‚îÄ patient002.fcs
‚îÇ   ‚îî‚îÄ‚îÄ ...
‚îú‚îÄ‚îÄ mixed_training/     # Labeled mixed samples for Phase 2
‚îÇ   ‚îú‚îÄ‚îÄ patient010_positive.fcs
‚îÇ   ‚îú‚îÄ‚îÄ patient011_negative.fcs
‚îÇ   ‚îî‚îÄ‚îÄ ...
‚îî‚îÄ‚îÄ mixed/             # Unlabeled samples for testing
    ‚îú‚îÄ‚îÄ sample001.fcs
    ‚îú‚îÄ‚îÄ sample002.fcs
    ‚îî‚îÄ‚îÄ ...
```

**Important**: For labeled training data (Phase 2), filenames must contain "positive" or "negative" to indicate AML status.

## üéÆ Usage

### Complete Two-Phase Training

Train both phases sequentially and generate visualizations:

```bash
python main.py --train-full --episodes 2000 --use-gpu
```

### Phase-by-Phase Training

**Phase 1 Only** (Quality learning on AML+ data):
```bash
python main.py --train-phase1 --episodes 1000
```

**Phase 2 Only** (Diagnostic refinement - requires Phase 1 Q-table):
```bash
python main.py --train-phase2 --episodes 1000 --q-table output/q_table.pkl
```

### Testing/Inference

Apply the learned policy to unlabeled data:

```bash
python main.py --test --input data/mixed/ --output output/predictions.csv --q-table output/q_table.pkl
```

### Generate Visualizations

Create plots from existing Q-table:

```bash
python main.py --visualize --q-table output/q_table.pkl
```

### Advanced Options

```bash
python main.py --help  # Show all options

# Custom configuration file
python main.py --train-full --config my_config.yaml

# Adjust logging verbosity
python main.py --train-full --log-level DEBUG

# Custom episode counts
python main.py --train-full --episodes 5000
```

## ‚öôÔ∏è Configuration

Edit `config.yaml` to customize:

### Data Paths
```yaml
data:
  positive: "data/positive/"
  mixed_training: "data/mixed_training/"
  mixed_test: "data/mixed/"
```

### Feature Discretization Thresholds
```yaml
discretization:
  state_features: ["CD45-ECD", "SS Log"]
  feature_bins:
    CD45-ECD: []  # To be determined from actual data
    SS Log: []    # To be determined from actual data
```

### Q-Learning Parameters
```yaml
q_learning:
  epsilon_start: 0.3      # Initial exploration rate
  epsilon_end: 0.05       # Minimum exploration rate
  epsilon_decay: 0.995    # Decay per episode
  learning_rate: 0.1      # Alpha (Œ±)
  discount_factor: 0.9    # Gamma (Œ≥)
  n_clusters_range: [2, 10]
```

### Training Parameters
```yaml
training:
  stage1_episodes: 1000   # Phase 1 iterations
  stage2_episodes: 1000   # Phase 2 iterations
  batch_size: 10          # Samples per iteration
```

## üß† How It Works

### 1. Feature Discretization

Continuous flow cytometry measurements are discretized into bins defined per feature (marker). Bin counts are configurable in config.yaml.

### 2. State Space

States encode discretized feature combinations:
- **2 features**: $b^2$ states
- **3 features**: $b^3$ states

Where $b$ is the number of bins per feature (e.g., $b=5$ gives 25 or 125 states).

### 3. Action Space

Actions represent cluster count selection: k ‚àà {2, 3, 4, 5, 6, 7, 8, 9, 10}

### 4. Q-Learning Algorithm

**Update Rule:**
```
Q(s,a) ‚Üê Q(s,a) + Œ±[r + Œ≥¬∑max Q(s',a') - Q(s,a)]
```

Where:
- s: current state
- a: selected action (cluster count)
- r: reward (silhouette score or F1-score)
- Œ±: learning rate (0.1)
- Œ≥: discount factor (0.9)

**Exploration Strategy:** Œµ-greedy with decay
- Start: Œµ = 0.3 (30% random exploration)
- End: Œµ = 0.05 (5% exploration)
- Decay: multiply by 0.995 each episode

### 5. Two-Phase Progressive Training

**Phase 1: Quality Optimization**
- Data: AML+ samples only
- Objective: Learn cluster counts that maximize silhouette score
- Reward: Silhouette score (cluster quality metric)
- Purpose: Understand structure of positive samples

**Phase 2: Diagnostic Refinement**
- Data: Mixed labeled samples (AML+ and AML-)
- Objective: Fine-tune for diagnostic accuracy
- Reward: F1-score or Matthews Correlation Coefficient
- Purpose: Optimize cluster-to-diagnosis mapping

## üìà Expected Results

After successful training, you should see:

1. **Learning Curves**: Rewards increasing over iterations
2. **Q-Value Convergence**: Q-table stabilizing with clear policies
3. **Action Distribution**: Preference for certain cluster counts
4. **Diagnostic Performance**: 
   - Accuracy: 70-90% (depends on data quality)
   - F1-Score: 0.65-0.85
   - Silhouette Score: 0.3-0.6 (higher = better separation)

## üìä Output Files

### Generated During Training

```
output/
‚îú‚îÄ‚îÄ q_table.pkl              # Trained Q-table (can be reloaded)
‚îú‚îÄ‚îÄ q_table_phase1.pkl       # After Phase 1 only
‚îú‚îÄ‚îÄ training.log             # Detailed execution log
‚îú‚îÄ‚îÄ plots/
‚îÇ   ‚îú‚îÄ‚îÄ phase1_learning_curve.png
‚îÇ   ‚îú‚îÄ‚îÄ phase2_learning_curve.png
‚îÇ   ‚îú‚îÄ‚îÄ q_value_heatmap.png
‚îÇ   ‚îú‚îÄ‚îÄ action_distribution.png
‚îÇ   ‚îú‚îÄ‚îÄ feature_distributions.png
‚îÇ   ‚îî‚îÄ‚îÄ training_summary.html
‚îî‚îÄ‚îÄ results.csv              # Predictions on test data
```

### Prediction Output Format

`results.csv` contains:
- `filename`: Original FCS filename
- `encoded_state`: Discrete state representation
- `selected_cluster_count`: Chosen k value
- `assigned_cluster`: Which cluster the sample belongs to
- `predicted_hiv_status`: "positive" or "negative" (Note: variable name retained for compatibility)

## üß™ Testing

Run unit tests to validate components:

```bash
# Install pytest
pip install pytest pytest-cov

# Run all tests
pytest tests/ -v

# Run specific test modules
pytest tests/test_discretizer.py -v
pytest tests/test_q_learning.py -v

# Generate coverage report
pytest tests/ --cov=src --cov-report=html
```

## üõ†Ô∏è Troubleshooting

### Problem: "No FCS files found"
**Solution**: Ensure FCS files are in correct directories and have `.fcs` extension

### Problem: "cuML not available"
**Solution**: Either install RAPIDS cuML or remove `--use-gpu` flag (will use CPU)

### Problem: "No labeled data found"
**Solution**: For Phase 2, filenames must contain "positive" or "negative"

### Problem: Poor performance
**Solutions**:
- Increase training episodes: `--episodes 5000`
- Adjust learning parameters in `config.yaml`
- Ensure sufficient labeled training data (>50 samples recommended)
- Check FCS file quality and marker availability

### Problem: "ImportError: fcsparser"
**Solution**: `pip install fcsparser`

## üéì Science Fair Presentation Tips

1. **Explain the Clinical Context**: Start with why AML classification matters and what flow cytometry measures

2. **Demonstrate Reinforcement Learning**: Use visualizations to show how the Q-table evolves during training

3. **Highlight Innovation**: Emphasize clinically-informed discretization vs. arbitrary binning

4. **Show Results**: Display learning curves, confusion matrices, and example predictions

5. **Discuss Trade-offs**: Simplicity (discretization) vs. accuracy, exploration vs. exploitation

6. **Future Work**: Mention potential improvements (deep Q-learning, more markers, larger datasets)

## üìö References

### Scientific Background
1. **AML Classification**: Understanding acute myeloid leukemia diagnosis and flow cytometry markers
2. **Flow Cytometry**: CD45 and side scatter analysis for blast cell identification
3. **FlowCAP Challenge**: Community benchmark for flow cytometry analysis

### Technical References
1. **Q-Learning**: Watkins & Dayan (1992) - "Q-learning"
2. **Reinforcement Learning**: Sutton & Barto - "Reinforcement Learning: An Introduction"
3. **FCS Format**: ISAC - Flow Cytometry Standard

## üìù License

This is an educational project for science fair purposes. The code is provided as-is for learning and demonstration.

## ü§ù Contributing

This is a science fair project, but suggestions and improvements are welcome! Please open an issue or submit a pull request.

## üìß Contact

For questions about this project, please open a GitHub issue.

## üôè Acknowledgments

- Medical community for AML classification criteria
- ISAC for FCS standard specification
- RAPIDS team for cuML GPU acceleration
- FlowCAP community for flow cytometry benchmarks

---

**Note**: This system is for educational/research purposes only and should not be used for clinical diagnosis without proper validation and regulatory approval.
